Article info

Download PDFPDF

Original research
Randomized phase II study of stereotactic body radiotherapy and interleukin-2 versus interleukin-2 in patients with metastatic melanoma

Authors

  1. Correspondence to Dr Brendan Curti; brendan.curti{at}providence.org
View Full Text

Citation

Curti B, Crittenden M, Seung SK, et al
Randomized phase II study of stereotactic body radiotherapy and interleukin-2 versus interleukin-2 in patients with metastatic melanoma

Publication history

  • Accepted April 23, 2020
  • First published May 27, 2020.
Online issue publication 
January 11, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.